Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: Findings from the Icatibant Outcome Survey / Aberer, Werner; Maurer, Marcus; Bouillet, Laurence; Zanichelli, Andrea; Caballero, Teresa; Longhurst, Hilary J.; Perrin, Amandine; Andresen, Irmgard; Wiednig, M.; Grumach, A.; Bygum, A.; Blanchard Delauny, C.; Boccon-Gibod, I.; Coppere, B.; Fain, O.; Goichot, B.; Gompel, A.; Guez, S.; Jeandel, P. Y.; Kanny, G.; Launay, D.; Maillard, H.; Martin, L.; Masseau, A.; Ollivier, Y.; Sobel, A.; Arnolds, J.; Aygören-Pürsün, E.; Bas, M.; Bauer, M.; Bork, K.; Magerl, M.; Martinez-Saguer, I.; Papadopoulou-Alataki, E.; Psarros, F.; Graif, Y.; Kivity, S.; Reshef, A.; Toubi, E.; Arcoleo, F.; Bova, M.; Cicardi, M.; Manconi, P.; Montinaro, V.; Marone, G.; Baeza, M. L.; Cabañas, R.; Guilarte, M.; Hernandez, D.; Hernando de Larramendi, C.; Lleonart, R.; Lobera, T.; Marques, L.; Saenz de San Pedro, B.; Bjoerkander, J.; Bethune, C.; Garcez Pereira, T.; Helbert, M.. - In: ALLERGY, ASTHMA, AND CLINICAL IMMUNOLOGY. - ISSN 1710-1484. - 13:1(2017), p. Article number 31. [10.1186/s13223-017-0203-z]
Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: Findings from the Icatibant Outcome Survey
Bova, M.;Marone, G.Membro del Collaboration Group
;
2017
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.